Leveraging Family-Based Assets for Black MSM In House Ball Communities
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05071378 |
Recruitment Status :
Enrolling by invitation
First Posted : October 8, 2021
Last Update Posted : October 8, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV I Infection | Behavioral: Our Family, Our Voices | Not Applicable |
Although there is access to effective HIV prevention tools such as pre-exposure prophylaxis (PrEP), Black men who have sex with men (MSM) continue to have the highest numbers of new HIV cases in the US and are unlikely to be linked to care or to have their HIV under control. Many Black MSM face many challenges because of racism and homophobia but some have found safety in the House Ball Community -an alternative family network (or houses) for Black LGBT that provide emotional and physical support and care and health information for its members. In this study, the investigators will modify a well-known, six-session group HIV prevention program for HIV-negative Black MSM, called Many Men Many Voices (3MV), and turn it into a family-based program that focuses on Black MSM with and without HIV in House Ball Communities. Family-based group programs have been shown to help prevent individuals from getting HIV; but, 3MV is not a family-based program. And in 3MV, Black MSM without HIV are usually recruited into groups with individuals they have never met before. 3MV doesn't usually use the connections between house ball family members to improve health outcomes and doesn't consider how house ball families have members who are both HIV-negative and HIV-positive. Because Black MSM in the House Ball Community have closer social relationships, 3MV requires modification to better fit the house family structure and how family members interact with each other. The goal in this study is to prepare for a larger study to test if the modified 3MV program works better to reduce new HIV infections and improve the health of HIV-positive Black MSM in the House Ball Community families compared to a no group program.
The investigators predict that a modified version of the 3MV group program for the House Ball Community families will work better than the original version of 3MV on HIV prevention and treatment outcomes. This study will provide important information to help us design and conduct a larger study of this modified version of 3MV called "Our Family Our Voices" on HIV prevention and care outcomes in Black MSM. By tailoring a program for the House Ball Community, this research to improve HIV testing and participation in care will better serve Black MSM-the highest priority group for HIV prevention in the United States.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 168 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | The investigators will determine the feasibility, acceptability and a preliminary estimate of effect size of an evidence-based HIV prevention intervention for Black MSM adapted for HIV status-neutral use with families in the HBC (called: OFOV). The eight-step ADAPT-ITT framework will guide the approach to enhance intervention content to incorporate an asset-building framework. Aim 1 will lead to the combined multi-level intervention adapted to improve congruence with the realities of HBC families. Aim 2 will assess the feasibility and acceptability of conducting a cluster randomized controlled trial of OFOV with a standard of care wait-listed control group. Data collected from the CRCT will be used to estimate the effect size of OFOV on HIV testing and PrEP use (primary outcome for HIV-negative participants), HIV care engagement and use of ARV treatment (primary outcome for PLHIV), as well as number of family-based assets and sexual health measures (status-neutral secondary outcomes). |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Leveraging Family-Based Assets for Black MSM In House Ball Communities (Our Family, Our Voices-"OFOV) |
Actual Study Start Date : | September 17, 2020 |
Estimated Primary Completion Date : | November 30, 2021 |
Estimated Study Completion Date : | November 30, 2021 |

Arm | Intervention/treatment |
---|---|
Experimental: Intervention Group
This arm will be enrolled in the intervention prior to any data collection
|
Behavioral: Our Family, Our Voices
Many Men, Many Voices (3MV) is a seven-session, group-level intervention developed to prevent HIV and sexually transmitted diseases (STDs) among black men who have sex with men (MSM) who may or may not identify themselves as gay. The intervention addresses factors that influence the behavior of black MSM: cultural, social, and religious norms; interactions between HIV and other STDs; sexual relationship dynamics; and the social influences that racism and homophobia have on HIV risk behaviors. Our Family, Our Voices seeks to create an adaptation of Many Men, Many Voices specifically tailored to young people who are members of the house ball community by incorporating elements of family support and resilience afforded to participants in the intervention.
Other Name: an adaptation of Many Men, Many Voices |
No Intervention: Wait listed control
This arm will receive the intervention after all study data is collected
|
- HIV testing [ Time Frame: measured at time 0, 3 months and 6 months ]primary outcome for HIV-negative participants: the change in the proportion of those who are HIV-negative having been tested for HIV at the three time point s
- HIV testing [ Time Frame: measured at time 0, 3 months and 6 months ]primary outcome for HIV-negative participants: total change in the number of HIV test results among those who are HIV-negative and have been tested for HIV at the 3 time points
- PrEP use [ Time Frame: measured at time 0, 3 months and 6 months ]primary outcome for HIV-negative participants: the change in the proportion of those who are HIV-negative who report taking PrEP at the three time points
- HIV care engagement [ Time Frame: measured at time 0, 3 months and 6 months ]primary outcome for participants living with HIV: the change in the proportion of those living with HIV who report medical visits at the three time points
- Taking ARV treatment [ Time Frame: measured at time 0, 3 months and 6 months ]primary outcome for participants living with HIV: the change in the proportion of those living with HIV who report taking ARV treatment at the three time points
- Viral load measurement [ Time Frame: measured at time 0, 3 months and 6 months ]primary outcome for participants living with HIV: the change in the proportion of those living with HIV with undetectable HIV viral loads among those taking ARV treatment at the 3 time points
- Family based assets 1: Sense of Community Scale [ Time Frame: measured at time 0, 3 months and 6 months ]The change in the aggregate scores of all study participants across the 3 times points as a secondary measurement to study impact of the intervention
- Family based assets 2: READY Tool [ Time Frame: measured at time 0, 3 months and 6 months ]The change in the aggregate scores of all study participants across the 3 times points as a secondary measurement to study impact of the intervention
- Family based assets 3: Asset Inventory [ Time Frame: measured at time 0, 3 months and 6 months ]The change in the Asset Inventory scores of all study participants across the 3 times points as a secondary measurement to study impact of the intervention
- Brief Resilience Scale [ Time Frame: measured at time 0, 3 months and 6 months ]The change in the aggregate scores of all study participants across the 3 times points as a secondary measurement to study impact of the intervention
- Condomless anal intercourse [ Time Frame: measured at time 0, 3 months and 6 months ]The change in the relative frequency = # times condoms used during anal sex / total # episodes of anal sex in the past 3 months among all study participants across the 3 times points as a secondary measurement to study impact of the intervention
- Number of sexual partners [ Time Frame: measured at time 0, 3 months and 6 months ]The change in the total number of sexual partners in the past 3 months among all study participants across the 3 times points as a secondary measurement to study impact of the intervention

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 30 Years (Adult) |
Sexes Eligible for Study: | All |
Gender Based Eligibility: | Yes |
Gender Eligibility Description: | At least half of the participating house members must be Black men who have sex with men. Black MSM must also currently self-identify as cisgender or transgender man, report anal sex with another man at least once within the previous six months (note: other HBC family members can identify as any gender). |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Eligibility for the study will be determined primarily at the family-level. At least 12 members of the same HBC family must be willing to participate together, of which at least half the participating members must be Black MSM.
Participating family members must reside in the New York City metro area.
Black MSM participants must be at least 18 years old.
Exclusion Criteria:
- Not being a member of a house ballroom community family
- Residing outside the New York City
- Being a member of a house ballroom community family that has been established less than 12 months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05071378
United States, New York | |
HEAT Program/SUNY Downstate Medical Center | |
Brooklyn, New York, United States, 11203 |
Responsible Party: | Jeffrey Birnbaum MD MPH, Associate Professor of Pediatrics, State University of New York - Downstate Medical Center |
ClinicalTrials.gov Identifier: | NCT05071378 |
Other Study ID Numbers: |
1555461 1R34MH124082-01 ( U.S. NIH Grant/Contract ) |
First Posted: | October 8, 2021 Key Record Dates |
Last Update Posted: | October 8, 2021 |
Last Verified: | September 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Product Manufactured in and Exported from the U.S.: | No |
Men House ballroom community transgender |